science bubbles in form of genetic module

Healthcare & Life Sciences

Across healthcare and community-based care, increasing demand creates opportunities but, when combined with capacity and funding needs, it creates challenges too. In life sciences, the cost and complexity of developing new products is rising and taking them to market takes more capital, evidence and commercial clarity than ever. We help clients cut through this complexity – identifying where and how to grow, setting pricing strategies that reflect market dynamics, and turning data into better decisions.

We help our clients

We help businesses prioritize, targeting the markets, services or products that offer the clearest path to growth. That includes evaluating white space, testing new propositions, and supporting international expansion.
We work with businesses to understand what customers or payors will pay – and where pricing strategy can unlock value. That includes assessing willingness to pay, benchmarking across geographies, and linking pricing to positioning.
What works in one market rarely works the same way elsewhere. We help clients navigate internationalization – identifying viable markets, understanding local structures, and tailoring commercial models.
Businesses often lack a full view of their own performance. We help clients access and apply the right data – to evaluate what’s working, what’s not, and where to invest next.
In both public and private markets, delivery is constrained by capacity. We help clients shape strategies that respond to that reality – from shifting to private pay models, to tech-enabled delivery, to rethinking service mix.

Case Studies

Expertise in action

Pricing headroom analysis

How did a healthcare business uncover pricing headroom, despite fears it had already hit the ceiling?

A healthcare business engaged CIL to explore pricing potential in its animal health division, amid concerns that prices had already reached their limit. CIL ran two targeted pricing surveys, revealing clear headroom in one service line while confirming that another was already well-positioned. Set against competitive trends, the results gave leadership confidence to invest, with a clear, data-backed path to profitable growth.

wave of data on dark blue background for healthcare provider

Operational cost diagnostics

How did a healthcare provider uncover the real costs affecting its margins?

A healthcare provider struggled to address investor questions about an emerging margin erosion issue. This became a business-critical issue and manual reporting just wasn’t cutting it. CIL built an automated diagnostic solution with Power BI, integrating data from scheduling, finance and payroll, uncovering an 843% rise in specific costs that prompted immediate action. With this new clarity, the client quickly tackled problem areas to protect margins.

Sub-sector expertise

We work across healthcare, life sciences and social care, covering the full breadth of the sector – from direct service delivery to technology, medical products, and the supply chains and infrastructure that support them.

Ready to get started?

Healthcare

Healthcare is evolving fast, shaped by rising demand, shifting patient expectations and accelerating innovation in care delivery and products. Businesses need to balance quality, cost and scalability while responding to more competitive, consumer-led markets. Our work brings clarity to where value is created across this landscape and what it takes to grow sustainably within it.

Care taker talking to older person in care home

Community-based care

In a sector where budgets remain tight and reform is slow, providers need to do more with less. We work across specialist care, elderly care, children’s services in a range of settings – helping clients develop sustainable delivery models and navigate complex commissioning environments.

Person looking at technology used in a healthcare organisations

Healthcare technology

We work with vendors, analytics platforms and workflow software providers to sharpen propositions, guide international rollout and drive adoption. Buyers want more than innovation – they want measurable impact. We help our clients show it.

two people in lab looking at medical results

Life sciences and pharma

From early-stage R&D to commercialization, we advise a range of pharmacos and pharma services businesses including CROs, CDMOs, regulatory affairs consultancies and pharma tech providers. Our work includes pricing, market entry, investor strategy and positioning, with a focus on leveraging scientific expertise to drive commercial success.

Animal health

We’ve worked across veterinary clinics and the wider animal health ecosystem – from pet nutrition and diagnostics to training – helping client’s price effectively, plan international growth, and compete in a fast-consolidating global market.

Our differentiator

We’ve worked across every corner of the sector – from pharma services to healthtech, diagnostics to social care. This depth means we don’t waste time getting up to speed and we know what to look for, what to question, and what makes the difference between a promising idea and a scalable one. Many of our team have worked in the sector themselves – so we focus on what’s practical, not theoretical. And because we work across Europe and North America, we bring a genuinely international view to every project. Clients trust us to bring clarity, not just analysis – and to deliver work that leads to action.